GSK-356278
CAS : 720704-34-7
Ref. 3D-VDB70434
| 1g | Arrêté | ||
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté |
Informations sur le produit
Nom :
GSK-356278
Description :
GSK-356278 is a phosphodiesterase inhibitor that has been shown to improve the symptoms of Alzheimer's disease. This drug is being developed for the treatment of other conditions, such as depression and schizophrenia. GSK-356278 inhibits PDE5, which is involved in the regulation of neurotransmitter release. This inhibition leads to increased levels of cAMP and subsequent activation of protein kinase A (PKA). PKA is a regulatory enzyme that phosphorylates serine residues on many proteins, including ion channels, receptors, enzymes, and transcription factors. GSK-356278 has also been shown to have an effect on synaptic dysfunction by increasing levels of nucleotides in rat brain tissue.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
439.54 g/mol
Formule :
C21H25N7O2S
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
